과제정보
The authors acknowledge Sun Hwa Choi and Young-Jin Lee (Quality control Team, Korea Vaccine Co., Ltd., Korea), Dr. Mayuko Okabe (Department of Immunology, National Institute of Infectious Diseases, Japan) for participating the collaborator study.
참고문헌
- Kasturiratne A, Wickremasinghe AR, de Silva N, Gunawardena NK, Pathmeswaran A, Premaratna R, Savioli L, Lalloo DG, de Silva HJ (2008) The global burden of snakebite: a literature analysis and modelling based on regional estimates of envenoming and deaths. PLoS Med 5:e218 https://doi.org/10.1371/journal.pmed.0050218
- Lim H, Kang HG, Kim KH (2013) Antivenom for snake bite in Korea. J Korean Med Assoc 56:1091-1103 https://doi.org/10.5124/jkma.2013.56.12.1091
- Gumprecht A, Tillack F, Orlov NL, Captain A (2004) Asian Pit vipers. Geitje Books, Berlin, p 368
- Eble JA (2010) Matrix biology meets toxinology. Matrix Biol 29:239-247 https://doi.org/10.1016/j.matbio.2010.01.004
- Kosuge T (1968) Biological toxicity of mamushi-snake venom (Agkistrodon halys) and morphological changes caused by the venom. Kitakanto Med 18:353-379 (in Japanese) https://doi.org/10.2974/kmj1951.18.353
- Teteno I, Sawaki Y, Makino M (1963) Current status of mamushi snake (Agkistrodon halys) bite in Japan with special reference to severe and fatal cases. Jpn J Exp Med 33:331-346
- Omori T, Iwanaga S, Suzuki T (1964) The relationship between the hemorrhagic and lethal of Japanese mamushi (Agkistrodon halys blomhoffii) venom. Toxicon 2:1-4 https://doi.org/10.1016/0041-0101(64)90027-3
- Gutierrez JM, Leon G, Lomonte B, Angulo Y (2011) Antivenoms for snakebite envenomings. Inflamm Allergy Drug Targets 10:369-380 https://doi.org/10.2174/187152811797200669
- Korea Food and Drug Administration (2011) Minimum requirement for biological products (in Korean)
- Fukuda T, Iwaki M, Hong SH, Oh HJ, Wei Z, Morokuma K, Ohkuma K, Dianliang L, Arakawa Y, Takahashi M (2006) Standardization of regional reference for mamushi (Gloydius blomhoffii) antivenom in Japan, Korea, and China. Jpn J Infect Dis 59:20-24
- Yoo SH, Park SJ, Kim SN, Hong CM (2004) Establishment of venom standard for potency test of Agkistrodon antivenom. Biol Prod Saf Monitor Rep 4:19-26
- Han K, Jung K, Oh H, Song H, Park S, Kim JH, Min G, Lee BH, Nam H, Ato M, Kim YJ, Jeong J, Ahn C (2018) A collaborative study to establish the second Korean national reference standard for snake venom. Toxicol Res 34:191-197 https://doi.org/10.5487/TR.2018.34.3.191
- World Health Organization (2010) WHO guidelines for the production control and regulation of snake antivenom immunoglobulins. World Health Organization, Geneva. https://www.who.int/bloodproducts/snake_antivenoms/snakeantivenomguide/en. Cited 1 January 2017
- Reed LJ, Muench H (1938) A simple method of estimating fifty percent endpoints. Am J Hyg 27:493-497
- Guidelines for national authorities on quality assurance for biological products. In: WHO Expert Committee on Biological Standardization. Forty-second Report. World Health Organization, Geneva. 1992, Annex 2 (WHO Technical Report Series, No. 822)
- Xu Y, Myers EA, Wang L, Huang S, He Y, Peng P, Guo P (2012) Molecular phylogeny of the genus Gloydius (Serpentes: Crotalinae). Asian Herpetol Res 3:127-132 https://doi.org/10.3724/SP.J.1245.2012.00127
- Kawashima Y (1974) Study of the immunological relationships between venom of six Asiatic Agkistrodons. Snake 6:16-26
피인용 문헌
- Adverse Reactions after Administration of Antivenom in Korea vol.12, pp.8, 2020, https://doi.org/10.3390/toxins12080507